Zhengye Biotechnology Holding Limited Announces Financial Results for the First Six Months of Fiscal Year 2026
Zhengye Biotechnology H1 EPS $(0.06), Same YoY, Sales $7.509M Down From $8.701M YoY
Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement
Zhengye Biotechnology Stock Plunges Following 322% Rally In Volatile Reversal
Zhengye Biotechnology Says No Material Events Behind Unusual Trading Activity (NASDAQ:ZYBT)
Zhengye Biotechnology Holding Limited Comments on Unusual Trading Activity
Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Zhengye Biotechnology Receives Nasdaq Listing Notice Of Failure To Maintain Minimum Bid Pricing Requirements
Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results
Zhengye Biotechnology FY EPS $(0.21) Down From $0.03 YoY, Sales $16.639M Down From $25.531M YoY
Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure
Zhengye Biotechnology Adopts Dual-Class Share Structure, Effective April 7
Zhengye Biotechnology Holding Limited Issues 2026 Chairman’s Letter to Shareholders
Zhengye Biotechnology Holding Releases 2026 Chairman's Shareholder
12 Health Care Stocks Moving In Thursday's After-Market Session
Is Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) ROE Of 3.8% Concerning?
RH Posts Downbeat Results, Joins Frequency Electronics, Tronox And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results
Zhengye Biotechnology FY EPS $0.03, Sales $25.531M
Zhengye Biotechnology Stock Is Trading Lower On Monday: What's Going On?
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.